Live Breaking News & Updates on Mantle Cell Lymphoma

Stay updated with breaking news from Mantle cell lymphoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Calquence Regimen Improves Outcomes in Frontline Mantle Cell Lymphoma

Adding Calquence to standard-of-care chemoimmunotherapy improved progression-free survival in patients with previously untreated mantle cell lymphoma. ....

Susan-galbraith , Michael-wang , Bendeka-treanda , Drug-administration , Eastern-cooperative-oncology-group , Astrazeneca , Md-anderson-cancer-center , Mantle-cell-lymphoma-program-of-excellence , Puddin-clarke-endowed-professor , Mantle-cell-lymphoma-program , Clinical-trials , Cancer-center

Dr Pearse on the Current Treatment Paradigm for Relapsed/Refractory MCL

William B. Pearse, MD, discusses the current treatment paradigm for patients with relapsed/refractory mantle cell lymphoma. ....

San-diego , California , United-states , Williamb-pearse , University-of-california , San-diego-school-of-medicine , San-diego-school , Uc-san-diego-health-moores-cancer-center , Onclive-tv , Mantle-cell-lymphoma , Cmcl

Longtime News-Herald contributor Steve Hare battles cancer for a third time

Steve Hare is well aware that he is in the battle of his life as he wages war for the third time against cancer. The Claridon Towship resident is also well aware more than ever that he isn’t fighting it alone. The owner and operator of OhioVarsity.com, who is also the sports information director for […] ....

Ohio , United-states , Berkshire , Michael-green , Ed-bradac , Steve-hare , Jo-bondra , Claridon-towship , Google , Lymphoma-research-foundation , Chagrin-valley-conference , Mantle-cell-lymphoma

TG Therapeutics: BRIUMVI Development Could Lead To Great Results (NASDAQ:TGTX)

TG Therapeutics: BRIUMVI Development Could Lead To Great Results (NASDAQ:TGTX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Michael-weiss , Benjamin-graham , Incyte-corporation , Biogen-inc , Trademark-office , Neuraxpharm-group , Tg-therapeutics-inc , Company-earnings-power-value , European-commission , Nasdaq

Observational Study Shows Frontline Ibrutinib With/Without Rituximab Is Safe and Effective in Low-Risk Mantle Cell Lymphoma

Ibrutinib with or without rituximab was effective and tolerable in patients with previously untreated, low-risk mantle cell lymphoma. ....

United-kingdom , Manchester , Ibrutinib-imbruvica , Ann-tivey , International-prognostic-score-index , University-of-manchester , Prognostic-score-index , Ibrutinib , Mantle-cell-lymphoma , Cmcl , Rituximab ,